Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunlin Zhuang

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
European Journal of Medicinal Chemistry|March 24, 2026
Targeting STAT3 in Alzheimer's disease: Potential mechanisms and therapeutic implicationsPeixian Chen, Rui Wang, Ting Zhou, et al.
Chemmedchem|May 21, 2016
Unambiguous Identification of β-Tubulin as the Direct Cellular Target Responsible for the Cytotoxicity of Chalcone by Photoaffinity LabelingBo Zhou, Xingxin Yu, Chunlin Zhuang, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 6, 2020
Enantioselective Total Syntheses of (-)-20-epi-Vincamine and (-)-20-epi-Eburnamonine by Ir-Catalyzed Asymmetric Imine Hydrogenation/Lactamization CascadeWen Zhang, Xiangtao Chen, Yi An, et al.
Bioorganic Chemistry|March 12, 2025
Structure-based molecular hybridization design and synthesis of Keap1-Nrf2 inhibitors for anti-inflammatory treatmentXiuting Qin, Ruilin Hou, Zhuo Qu, et al.
Food & Function|December 12, 2023
Diallyl trisulfide inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer <i>via</i> modulating gut microbiota and the PPARγ/NF-κB pathwayZhuo Qu, Jiahui Tian, Jiachen Sun, et al.
Acta Pharmaceutica Sinica. B|February 22, 2020
Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitorsKaijun Jin, Minjie Liu, Chunlin Zhuang, et al.
Bioorganic Chemistry|May 19, 2019
Follow on-based optimization of the biphenyl-DAPYs as HIV-1 nonnucleoside reverse transcriptase inhibitors against the wild-type and mutant strainsYali Sang, Sheng Han, Shuwen Han, et al.
European Journal of Medicinal Chemistry|September 28, 2021
Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channelXin Jin, Hu-Ri Piao, Christophe Pannecouque, et al.
European Journal of Medicinal Chemistry|November 26, 2024
Comprehensive exploration of isocitrate dehydrogenase (IDH) mutations: Tumorigenesis, drug discovery, and covalent inhibitor advancesConghao Gai, Hairong Zeng, Haoming Xu, et al.
European Journal of Medicinal Chemistry|June 13, 2021
Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injuryLe Zhang, Lijuan Xu, Haihu Chen, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
European Journal of Medicinal Chemistry|March 24, 2026
Targeting STAT3 in Alzheimer's disease: Potential mechanisms and therapeutic implicationsPeixian Chen, Rui Wang, Ting Zhou, et al.
Chemmedchem|May 21, 2016
Unambiguous Identification of β-Tubulin as the Direct Cellular Target Responsible for the Cytotoxicity of Chalcone by Photoaffinity LabelingBo Zhou, Xingxin Yu, Chunlin Zhuang, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 6, 2020
Enantioselective Total Syntheses of (-)-20-epi-Vincamine and (-)-20-epi-Eburnamonine by Ir-Catalyzed Asymmetric Imine Hydrogenation/Lactamization CascadeWen Zhang, Xiangtao Chen, Yi An, et al.
Bioorganic Chemistry|March 12, 2025
Structure-based molecular hybridization design and synthesis of Keap1-Nrf2 inhibitors for anti-inflammatory treatmentXiuting Qin, Ruilin Hou, Zhuo Qu, et al.
Food & Function|December 12, 2023
Diallyl trisulfide inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer <i>via</i> modulating gut microbiota and the PPARγ/NF-κB pathwayZhuo Qu, Jiahui Tian, Jiachen Sun, et al.
Acta Pharmaceutica Sinica. B|February 22, 2020
Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitorsKaijun Jin, Minjie Liu, Chunlin Zhuang, et al.
Bioorganic Chemistry|May 19, 2019
Follow on-based optimization of the biphenyl-DAPYs as HIV-1 nonnucleoside reverse transcriptase inhibitors against the wild-type and mutant strainsYali Sang, Sheng Han, Shuwen Han, et al.
European Journal of Medicinal Chemistry|September 28, 2021
Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channelXin Jin, Hu-Ri Piao, Christophe Pannecouque, et al.
European Journal of Medicinal Chemistry|November 26, 2024
Comprehensive exploration of isocitrate dehydrogenase (IDH) mutations: Tumorigenesis, drug discovery, and covalent inhibitor advancesConghao Gai, Hairong Zeng, Haoming Xu, et al.
European Journal of Medicinal Chemistry|June 13, 2021
Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injuryLe Zhang, Lijuan Xu, Haihu Chen, et al.
Pageof 15